Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,273,813 papers from all fields of science
Search
Sign In
Create Free Account
dalfopristin
Known as:
Dalfopristine
, Dalfopristinum
, Dalfopristina
Expand
A semi-synthetic derivative of streptogramin A produced by streptomycetes. Dalfopristin inhibits the early phase of protein synthesis in the…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
13 relations
Broader (2)
Anti-Bacterial Agents
Virginiamycin
Bacterial Infections
Decreased Protein Synthesis [PE]
Drug Allergy
Protein Synthesis Inhibitors [MoA]
Expand
Narrower (2)
RP 54476
Synercid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Incidence, prevalence, and management of MRSA bacteremia across patient populations—a review of recent developments in MRSA management and treatment
A. Hassoun
,
P. Linden
,
B. Friedman
Critical Care
2017
Corpus ID: 1269005
Methicillin-resistant Staphylococcus aureus (MRSA) infection is still a major global healthcare problem. Of concern is S. aureus…
Expand
Highly Cited
2007
Highly Cited
2007
Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
L. Deshpande
,
T. Fritsche
,
Gary J. Moet
,
D. Biedenbach
,
Ronald N. Jones
Diagnostic microbiology and infectious disease
2007
Corpus ID: 37914671
Review
2006
Review
2006
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.
C. Gemmell
,
D. I. Edwards
,
A. Fraise
,
F. Gould
,
G. Ridgway
,
R. Warren
Journal of Antimicrobial Chemotherapy
2006
Corpus ID: 2045051
These evidence-based guidelines have been produced after a literature review of the treatment and prophylaxis of methicillin…
Expand
Review
2005
Review
2005
Mechanisms of action of newer antibiotics for Gram-positive pathogens.
R. Hancock
Lancet. Infectious Diseases (Print)
2005
Corpus ID: 10675285
Highly Cited
2004
Highly Cited
2004
BSAC standardized disc susceptibility testing method (version 8).
J. Andrews
Journal of Antimicrobial Chemotherapy
2004
Corpus ID: 1760507
There have been considerable changes to the format of the recommendations since the previous version (version 7). The majority of…
Expand
Review
2004
Review
2004
Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.
Christopher F Carpenter
,
Henry F Chambers
Clinical Infectious Diseases
2004
Corpus ID: 265822643
Daptomycin is a novel cyclic lipopeptide antibiotic that provides rapid bactericidal activity against gram-positive pathogens in…
Expand
Highly Cited
2002
Highly Cited
2002
An Enterococcus faecalis ABC Homologue (Lsa) Is Required for the Resistance of This Species to Clindamycin and Quinupristin-Dalfopristin
Kavindra V. Singh
,
G. Weinstock
,
B. Murray
Antimicrobial Agents and Chemotherapy
2002
Corpus ID: 24458775
ABSTRACT Enterococcus faecalis isolates are resistant to clindamycin (CLI) and quinupristin-dalfopristin (Q-D), and this is…
Expand
Review
2001
Review
2001
Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know.
R. Weinstein
,
S. Fridkin
Clinical Infectious Diseases
2001
Corpus ID: 2981963
Ever since the first strain of Staphylococcus aureus with reduced susceptibility to vancomycin and teicoplanin was reported from…
Expand
Review
2000
Review
2000
Antibiotic resistance in staphylococci.
D. Livermore
International Journal of Antimicrobial Agents
2000
Corpus ID: 20500264
Highly Cited
2000
Highly Cited
2000
In Vitro Activities of Daptomycin, Vancomycin, Linezolid, and Quinupristin-Dalfopristin against Staphylococci and Enterococci, Including Vancomycin- Intermediate and -Resistant Strains
M. Rybak
,
E. Hershberger
,
Tabitha Moldovan
,
Richard G. Grucz
Antimicrobial Agents and Chemotherapy
2000
Corpus ID: 10218439
ABSTRACT The in vitro activity of daptomycin was compared with those of vancomycin, linezolid, and quinupristin-dalfopristin…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE